Cargando…
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
AIM: To determine if manipulation of dietary advanced glycation end product (AGE), intake affects non-alcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS: Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 w...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028816/ https://www.ncbi.nlm.nih.gov/pubmed/27672297 http://dx.doi.org/10.3748/wjg.v22.i35.8026 |
_version_ | 1782454404485480448 |
---|---|
author | Leung, Christopher Herath, Chandana B Jia, Zhiyuan Andrikopoulos, Sof Brown, Bronwyn E Davies, Michael J Rivera, Leni R Furness, John B Forbes, Josephine M Angus, Peter W |
author_facet | Leung, Christopher Herath, Chandana B Jia, Zhiyuan Andrikopoulos, Sof Brown, Bronwyn E Davies, Michael J Rivera, Leni R Furness, John B Forbes, Josephine M Angus, Peter W |
author_sort | Leung, Christopher |
collection | PubMed |
description | AIM: To determine if manipulation of dietary advanced glycation end product (AGE), intake affects non-alcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS: Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 wk and compared with animals on normal chow. A third group were given a HFHC diet that was high in AGEs. Another group was given a HFHC diet that was marinated in vinegar to prevent the formation of AGEs. In a second experiment, RAGE KO animals were fed a HFHC diet or a high AGE HFHC diet and compared with wildtype controls. Hepatic biochemistry, histology, picrosirius red morphometry and hepatic mRNA were determined. RESULTS: Long-term consumption of the HFHC diet generated significant steatohepatitis and fibrosis after 33 wk. In this model, hepatic 4-hydroxynonenal content (a marker of chronic oxidative stress), hepatocyte ballooning, picrosirius red staining, α-smooth muscle actin and collagen type 1A gene expression were all significantly increased. Increasing the AGE content of the HFHC diet by baking further increased these markers of liver damage, but this was abrogated by pre-marination in acetic acid. In response to the HFHC diet, RAGE(-/-) animals developed NASH of similar severity to RAGE(+/+) animals but were protected from the additional harmful effects of the high AGE containing diet. Studies in isolated Kupffer cells showed that AGEs increase cell proliferation and oxidative stress, providing a likely mechanism through which these compounds contribute to liver injury. CONCLUSION: In the HFHC model of NAFLD, manipulation of dietary AGEs modulates liver injury, inflammation, and liver fibrosis via a RAGE dependent pathway. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD. |
format | Online Article Text |
id | pubmed-5028816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-50288162016-09-27 Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease Leung, Christopher Herath, Chandana B Jia, Zhiyuan Andrikopoulos, Sof Brown, Bronwyn E Davies, Michael J Rivera, Leni R Furness, John B Forbes, Josephine M Angus, Peter W World J Gastroenterol Basic Study AIM: To determine if manipulation of dietary advanced glycation end product (AGE), intake affects non-alcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS: Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 wk and compared with animals on normal chow. A third group were given a HFHC diet that was high in AGEs. Another group was given a HFHC diet that was marinated in vinegar to prevent the formation of AGEs. In a second experiment, RAGE KO animals were fed a HFHC diet or a high AGE HFHC diet and compared with wildtype controls. Hepatic biochemistry, histology, picrosirius red morphometry and hepatic mRNA were determined. RESULTS: Long-term consumption of the HFHC diet generated significant steatohepatitis and fibrosis after 33 wk. In this model, hepatic 4-hydroxynonenal content (a marker of chronic oxidative stress), hepatocyte ballooning, picrosirius red staining, α-smooth muscle actin and collagen type 1A gene expression were all significantly increased. Increasing the AGE content of the HFHC diet by baking further increased these markers of liver damage, but this was abrogated by pre-marination in acetic acid. In response to the HFHC diet, RAGE(-/-) animals developed NASH of similar severity to RAGE(+/+) animals but were protected from the additional harmful effects of the high AGE containing diet. Studies in isolated Kupffer cells showed that AGEs increase cell proliferation and oxidative stress, providing a likely mechanism through which these compounds contribute to liver injury. CONCLUSION: In the HFHC model of NAFLD, manipulation of dietary AGEs modulates liver injury, inflammation, and liver fibrosis via a RAGE dependent pathway. This suggests that pharmacological and dietary strategies targeting the AGE/RAGE pathway could slow the progression of NAFLD. Baishideng Publishing Group Inc 2016-09-21 2016-09-21 /pmc/articles/PMC5028816/ /pubmed/27672297 http://dx.doi.org/10.3748/wjg.v22.i35.8026 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Basic Study Leung, Christopher Herath, Chandana B Jia, Zhiyuan Andrikopoulos, Sof Brown, Bronwyn E Davies, Michael J Rivera, Leni R Furness, John B Forbes, Josephine M Angus, Peter W Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title_full | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title_fullStr | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title_full_unstemmed | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title_short | Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
title_sort | dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028816/ https://www.ncbi.nlm.nih.gov/pubmed/27672297 http://dx.doi.org/10.3748/wjg.v22.i35.8026 |
work_keys_str_mv | AT leungchristopher dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT herathchandanab dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT jiazhiyuan dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT andrikopoulossof dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT brownbronwyne dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT daviesmichaelj dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT riveralenir dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT furnessjohnb dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT forbesjosephinem dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease AT anguspeterw dietaryadvancedglycationendproductsaggravatenonalcoholicfattyliverdisease |